• Imaging Neurodegeneration and Repair in Multiple Sclerosis

    Imaging Neurodegeneration and Repair in Multiple Sclerosis

    Keynote Speaker: David Miller (University College London)Presented by the New York Academy of Sciences
    Reported by Kristen Delevich | Posted August 23, 2012


    Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. Current magnetic resonance imaging (MRI) techniques play a crucial role in the diagnosis of multiple sclerosis and advances in the technology are providing researchers with an increasingly nuanced picture of the disease and its progression. On June 15–16, 2012, a diverse group of researchers, physicians, and other professionals interested in how technological advances can improve the understanding and treatment of multiple sclerosis met at a New York Academy of Sciences conference titled Imaging Neurodegeneration and Repair in Multiple Sclerosis to exchange ideas and learn about the latest research in this field.

    Researchers at the conference presented results on detailed visualization of grey matter, myelin, and regional connectivity. They demonstrated novel techniques to track the progress of lesions and metabolic changes in brain tissue, and to correlate changes in the physical structure of the CNS with disease symptoms. Clinicians discussed ways to translate these research techniques to patient care.

    Use the tab above to find a meeting report and multimedia from this event.


    Presentations available from:
    Sean Deoni, PhD (Brown University School of Engineering)
    Elizabeth Fisher, PhD (Cleveland Clinic Lerner Research Institute)
    Matilde Inglese, MD, PhD (Mount Sinai School of Medicine)
    David Miller, MD (University College London)
    Govind Nair, PhD (National Institute of Neurological Disorder and Stroke, NIH)
    Robert T. Naismith, MD (Washington University)
    Daniel Pelletier, MD (Yale University School of Medicine)
    Istvan Pirko, MD (Mayo Clinic)
    Daniel S. Reich, MD, PhD (National Institute of Neurological Disorders and Stroke, NIH)
    Shiv Saidha, MBBCh, MRCPI (Johns Hopkins University School of Medicine)
    Klaus Schmierer, PhD, FRCP (Barts and the London School of Medicine & Dentistry)
    Erik M. Shapiro, PhD (Yale University School of Medicine)
    Bruno Stankoff, MD, PhD (Pierre and Marie Curie University, ICM, INSERM)
    Jerry S. Wolinsky, MD (University of Texas Health Science Center at Houston)

    Image courtesy of D. Reich, G. Nair, and C. Pardo-Villamizar, National Institute of Neurological Disorders and Stroke.

    Silver Sponsor

    • Teva Neuroscience